Literature DB >> 7556441

Localization and in situ phosphorylation state of nuclear tau.

J A Greenwood1, G V Johnson.   

Abstract

The localization and phosphorylation state of tau in LA-N-5 neuroblastoma cells was examined. Our results demonstrate that there are two populations of tau in LA-N-5 cells: cytosolic tau and nuclear tau. Indirect immunofluorescent microscopy revealed that nuclear tau is specifically localized to the nucleolus while cytosolic tau is diffusely distributed. To localize and quantitate tau in LA-N-5 cells by subcellular fractionation, a method was developed to extract tau from the nucleus while preserving the endogenous state of the protein. These studies revealed that 16% of the total tau protein in LA-N-5 cells is located in the nucleus and more specifically was found predominantly in the chromatin fraction containing DNA, chromatin, and associated proteins. The phosphorylation state of nuclear and cytosolic tau was examined by labeling LA-N-5 cells with 32Pi and immunoprecipitating tau from the different fractions. These data demonstrated that nuclear tau and cytosolic tau are phosphorylated approximately to the same extent. To determine if the phosphorylation of nuclear tau occurs in the nucleus, LA-N-5 nuclei were isolated, incubated with [gamma-32P]ATP, extracted, and tau was immunoprecipitated. Although numerous nuclear proteins were 32P-labeled, tau was not phosphorylated. These results suggest that nuclear tau is not phosphorylated in the nucleus but rather in the cytosol prior to transport into the nucleus. The specific localization of nuclear tau strongly suggests that it has a functional role in the nucleus. However, further studies are necessary to determine the function of nuclear tau and how it may be regulated by phosphorylation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7556441     DOI: 10.1006/excr.1995.1323

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  28 in total

1.  Tau dephosphorylation at tau-1 site correlates with its association to cell membrane.

Authors:  M Arrasate; M Pérez; J Avila
Journal:  Neurochem Res       Date:  2000-01       Impact factor: 3.996

Review 2.  Pathological implications of nucleic acid interactions with proteins associated with neurodegenerative diseases.

Authors:  Yraima Cordeiro; Bruno Macedo; Jerson L Silva; Mariana P B Gomes
Journal:  Biophys Rev       Date:  2014-01-09

Review 3.  Amyloid Precursor Protein (APP) Metabolites APP Intracellular Fragment (AICD), Aβ42, and Tau in Nuclear Roles.

Authors:  Gerhard Multhaup; Otmar Huber; Luc Buée; Marie-Christine Galas
Journal:  J Biol Chem       Date:  2015-08-21       Impact factor: 5.157

Review 4.  Sarin (GB, O-isopropyl methylphosphonofluoridate) neurotoxicity: critical review.

Authors:  Mohamed B Abou-Donia; Briana Siracuse; Natasha Gupta; Ashly Sobel Sokol
Journal:  Crit Rev Toxicol       Date:  2016-10-05       Impact factor: 5.635

5.  Nuclear tau, a key player in neuronal DNA protection.

Authors:  Audrey Sultan; Fabrice Nesslany; Marie Violet; Séverine Bégard; Anne Loyens; Smail Talahari; Zeyni Mansuroglu; Daniel Marzin; Nicolas Sergeant; Sandrine Humez; Morvane Colin; Eliette Bonnefoy; Luc Buée; Marie-Christine Galas
Journal:  J Biol Chem       Date:  2010-12-03       Impact factor: 5.157

Review 6.  Roles of tau protein in health and disease.

Authors:  Tong Guo; Wendy Noble; Diane P Hanger
Journal:  Acta Neuropathol       Date:  2017-04-06       Impact factor: 17.088

7.  Patched1 interacts with cyclin B1 to regulate cell cycle progression.

Authors:  E A Barnes; M Kong; V Ollendorff; D J Donoghue
Journal:  EMBO J       Date:  2001-05-01       Impact factor: 11.598

8.  The endogenous and cell cycle-dependent phosphorylation of tau protein in living cells: implications for Alzheimer's disease.

Authors:  S Illenberger; Q Zheng-Fischhöfer; U Preuss; K Stamer; K Baumann; B Trinczek; J Biernat; R Godemann; E M Mandelkow; E Mandelkow
Journal:  Mol Biol Cell       Date:  1998-06       Impact factor: 4.138

9.  The Pseudomonas aeruginosa exoenzyme Y impairs endothelial cell proliferation and vascular repair following lung injury.

Authors:  Trevor C Stevens; Cristhiaan D Ochoa; K Adam Morrow; Matthew J Robson; Nutan Prasain; Chun Zhou; Diego F Alvarez; Dara W Frank; Ron Balczon; Troy Stevens
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-04-04       Impact factor: 5.464

10.  Tau Mutations Serve as a Novel Risk Factor for Cancer.

Authors:  Giacomina Rossi; Veronica Redaelli; Paolo Contiero; Sabrina Fabiano; Giovanna Tagliabue; Paola Perego; Luisa Benussi; Amalia C Bruni; Graziella Filippini; Mariangela Farinotti; Giorgio Giaccone; Simona Buiatiotis; Claudia Manzoni; Raffaele Ferrari; Fabrizio Tagliavini
Journal:  Cancer Res       Date:  2018-05-24       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.